---
title: Ramelteon
description: >-
  - Ramelteon is prescribed for the treatment of insomnia characterized by
  difficulty with sleep onset. It helps patients fall asleep faster. -
  **Pharmacological classification:** Melatonin receptor agonist, hypnotic, and
  sedative. - **Mechanism of Action:** Ramelteon selectively binds to
  melatonin...
is_banned: false
lastModified: '2025-09-22T17:21:54.020Z'
faqs:
  - q: >-
      What is the recommended dosage for Ramelteon?**

      **A:** 8 mg orally taken within 30 minutes of bedtime for adults. Not
      recommended for children under 18.
    a: >-
      A:** 8 mg orally taken within 30 minutes of bedtime for adults. Not
      recommended for children under 18.
  - q: >-
      How does Ramelteon differ from other hypnotics?**

      **A:**  Ramelteon targets MT<sub>1</sub> and MT<sub>2</sub> receptors,
      unlike benzodiazepines or Z-drugs, offering a different mechanism of
      action. It is not a controlled substance and carries a lower risk of
      dependence.
    a: >-
      A:**  Ramelteon targets MT<sub>1</sub> and MT<sub>2</sub> receptors,
      unlike benzodiazepines or Z-drugs, offering a different mechanism of
      action. It is not a controlled substance and carries a lower risk of
      dependence.
  - q: >-
      Can Ramelteon be taken with food?**

      **A:** It should not be taken with or immediately after a high-fat meal,
      as this can reduce and delay absorption.
    a: >-
      A:** It should not be taken with or immediately after a high-fat meal, as
      this can reduce and delay absorption.
  - q: >-
      Are there any contraindications to Ramelteon use?**

      **A:** Yes, contraindications include hypersensitivity, history of
      angioedema with ramelteon, and concomitant fluvoxamine use.
    a: >-
      A:** Yes, contraindications include hypersensitivity, history of
      angioedema with ramelteon, and concomitant fluvoxamine use.
  - q: >-
      What are the most common side effects of Ramelteon?**

      **A:** Common side effects include drowsiness, dizziness, fatigue, nausea,
      and headache.
    a: >-
      A:** Common side effects include drowsiness, dizziness, fatigue, nausea,
      and headache.
  - q: >-
      Can Ramelteon be used during pregnancy or breastfeeding?**

      **A:** Ramelteon is Pregnancy Category C and should only be used if the
      potential benefit outweighs the potential fetal risk. It's not recommended
      while breastfeeding.
    a: >-
      A:** Ramelteon is Pregnancy Category C and should only be used if the
      potential benefit outweighs the potential fetal risk. It's not recommended
      while breastfeeding.
  - q: >-
      Does Ramelteon have any significant drug interactions?**

      **A:** Yes, it interacts with fluvoxamine (contraindicated), fluconazole,
      ketoconazole, rifampin, and CNS depressants.
    a: >-
      A:** Yes, it interacts with fluvoxamine (contraindicated), fluconazole,
      ketoconazole, rifampin, and CNS depressants.
  - q: >-
      Can patients develop tolerance or dependence to Ramelteon?**

      **A:**  Unlike many other hypnotics, Ramelteon does not appear to cause
      dependence or withdrawal symptoms, even after long-term use.
    a: >-
      A:**  Unlike many other hypnotics, Ramelteon does not appear to cause
      dependence or withdrawal symptoms, even after long-term use.
  - q: >-
      How long does it take for Ramelteon to work?**

      **A:** Ramelteon is designed to shorten the time it takes to fall asleep,
      with effects usually noticed within 30 minutes of administration.
    a: >-
      A:** Ramelteon is designed to shorten the time it takes to fall asleep,
      with effects usually noticed within 30 minutes of administration.
  - q: >-
      What should patients do if they experience complex sleep behaviors while
      taking Ramelteon?**

      **A:**  Patients should discontinue use and immediately contact their
      doctor if they experience complex sleep behaviors like sleepwalking,
      sleep-driving, or sleep-eating.
    a: >-
      A:**  Patients should discontinue use and immediately contact their doctor
      if they experience complex sleep behaviors like sleepwalking,
      sleep-driving, or sleep-eating.
---
## **Usage**

- Ramelteon is prescribed for the treatment of insomnia characterized by difficulty with sleep onset. It helps patients fall asleep faster.
- **Pharmacological classification:** Melatonin receptor agonist, hypnotic, and sedative.
- **Mechanism of Action:** Ramelteon selectively binds to melatonin MT<sub>1</sub> and MT<sub>2</sub> receptors in the suprachiasmatic nucleus (SCN) of the hypothalamus, mimicking the sleep-promoting effects of endogenous melatonin and regulating the circadian rhythm.

## **Alternate Names**

- Rozerem (brand name)

## **How It Works**

- **Pharmacodynamics:**  Ramelteon promotes sleep by binding to MT<sub>1</sub> and MT<sub>2</sub> receptors. It specifically targets sleep onset rather than sleep maintenance.
- **Pharmacokinetics:**
    - **Absorption:** Well-absorbed orally, but high-fat meals can decrease and delay absorption.
    - **Metabolism:** Extensively metabolized by the liver, primarily by CYP1A2 and to a lesser extent by CYP2C9 and CYP3A4 enzymes.
    - **Elimination:** Primarily eliminated through hepatic metabolism, with metabolites excreted in urine and feces. Elimination half-life is approximately 1-2.6 hours.
- **Mode of Action:**  Ramelteon selectively agonizes MT<sub>1</sub> and MT<sub>2</sub> receptors in the SCN, mimicking melatonin's effects on the sleep-wake cycle.
- **Receptor Binding:**  High affinity for MT<sub>1</sub> and MT<sub>2</sub> receptors, with no significant binding to other receptors, including GABA, benzodiazepine, dopamine, serotonin, or opioid receptors.
- **Elimination Pathways:** Hepatic metabolism (CYP1A2, CYP2C9, CYP3A4) followed by renal and fecal excretion of metabolites.

## **Dosage**

### **Standard Dosage**

#### **Adults:**
- 8 mg orally within 30 minutes of bedtime.
- Maximum dose: 8 mg per day.

#### **Children:**
- Not recommended for use in patients under 18 years of age. Safety and efficacy have not been established.

#### **Special Cases:**

- **Elderly Patients:** No specific dose adjustment is required, but initiate therapy with caution.
- **Patients with Renal Impairment:** No dose adjustment is necessary.
- **Patients with Hepatic Dysfunction:** Use with caution in moderate hepatic impairment (Child-Pugh B). Not recommended in severe hepatic impairment (Child-Pugh C).
- **Patients with Comorbid Conditions:** Use cautiously in patients with severe sleep apnea, depression, or a history of suicidal ideation.

### **Clinical Use Cases**

- Ramelteon is specifically indicated for insomnia characterized by difficulty with sleep onset. It is not typically used in settings like intubation, surgical procedures, mechanical ventilation, ICU, or emergency situations.

### **Dosage Adjustments**
- Dose adjustments may be necessary based on hepatic function and concomitant medications.  

## **Side Effects**

### **Common Side Effects**
- Drowsiness
- Dizziness
- Fatigue
- Nausea
- Headache

### **Rare but Serious Side Effects**
- Angioedema
- Anaphylaxis
- Worsening of depression
- Suicidal thoughts or behavior
- Complex sleep-related behaviors (e.g., sleepwalking, sleep-driving, sleep-eating)
- Hallucinations
- Hormonal changes (decreased testosterone, increased prolactin)


### **Long-Term Effects**
- Potential long-term effects on the reproductive axis are unknown.

### **Adverse Drug Reactions (ADR)**
- Angioedema and anaphylaxis require immediate medical attention.

## **Contraindications**

- Hypersensitivity to ramelteon
- History of angioedema with ramelteon
- Concomitant use of fluvoxamine

## **Drug Interactions**

- **CYP1A2 Inhibitors:** Fluvoxamine is contraindicated. Other CYP1A2 inhibitors may increase ramelteon levels.
- **CYP2C9 Inhibitors:** Fluconazole increases ramelteon exposure. Use with caution.
- **CYP3A4 Inhibitors:** Ketoconazole increases ramelteon exposure. Use with caution.
- **CYP Enzyme Inducers:** Rifampin decreases ramelteon levels.
- **CNS Depressants:** Alcohol and other sedatives can increase CNS depression. Use with caution.
- Other potential interacting drugs include donepezil, doxepin, and zolpidem.


## **Pregnancy and Breastfeeding**

- **Pregnancy Safety Category:** C (historical)
- **Fetal Risks:** Potential teratogenic effects observed in animal studies at high doses. No adequate and well-controlled studies in pregnant women. Use only if potential benefit outweighs potential risk.
- **Breastfeeding:**  Ramelteon is present in animal milk.  It's unknown if it passes into human breast milk. Breastfeeding is not recommended within 25 hours of taking ramelteon.


## **Drug Profile Summary**

- **Mechanism of Action:** Selective MT<sub>1</sub> and MT<sub>2</sub> receptor agonist.
- **Side Effects:** Drowsiness, dizziness, fatigue, nausea, headache.  Rarely: angioedema, anaphylaxis, complex sleep behaviors, hallucinations, mood changes.
- **Contraindications:** Hypersensitivity, angioedema history with ramelteon, concomitant fluvoxamine.
- **Drug Interactions:** Fluvoxamine, fluconazole, ketoconazole, rifampin, CNS depressants.
- **Pregnancy & Breastfeeding:** Category C; not recommended while breastfeeding.
- **Dosage:** 8 mg orally 30 minutes before bed.  Maximum 8 mg/day.
- **Monitoring Parameters:**  Sleep latency, adverse effects, mood changes, hormonal levels (if indicated).

## **Popular Combinations**

- Ramelteon is typically not used in combination with other sleep medications.


## **Precautions**

- Evaluate for underlying psychiatric or medical causes of insomnia.
- Monitor for complex sleep behaviors.
- Monitor patients with depression or suicidal ideation.
- Avoid alcohol.
- Avoid activities requiring alertness until effects are known.

## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Ramelteon?**
**A:** 8 mg orally taken within 30 minutes of bedtime for adults. Not recommended for children under 18.

### **Q2: How does Ramelteon differ from other hypnotics?**
**A:**  Ramelteon targets MT<sub>1</sub> and MT<sub>2</sub> receptors, unlike benzodiazepines or Z-drugs, offering a different mechanism of action. It is not a controlled substance and carries a lower risk of dependence.

### **Q3: Can Ramelteon be taken with food?**
**A:** It should not be taken with or immediately after a high-fat meal, as this can reduce and delay absorption.

### **Q4: Are there any contraindications to Ramelteon use?**
**A:** Yes, contraindications include hypersensitivity, history of angioedema with ramelteon, and concomitant fluvoxamine use.

### **Q5: What are the most common side effects of Ramelteon?**
**A:** Common side effects include drowsiness, dizziness, fatigue, nausea, and headache.

### **Q6: Can Ramelteon be used during pregnancy or breastfeeding?**
**A:** Ramelteon is Pregnancy Category C and should only be used if the potential benefit outweighs the potential fetal risk. It's not recommended while breastfeeding.

### **Q7: Does Ramelteon have any significant drug interactions?**
**A:** Yes, it interacts with fluvoxamine (contraindicated), fluconazole, ketoconazole, rifampin, and CNS depressants.

### **Q8: Can patients develop tolerance or dependence to Ramelteon?**
**A:**  Unlike many other hypnotics, Ramelteon does not appear to cause dependence or withdrawal symptoms, even after long-term use.


### **Q9:  How long does it take for Ramelteon to work?**
**A:** Ramelteon is designed to shorten the time it takes to fall asleep, with effects usually noticed within 30 minutes of administration.

### **Q10:  What should patients do if they experience complex sleep behaviors while taking Ramelteon?**
**A:**  Patients should discontinue use and immediately contact their doctor if they experience complex sleep behaviors like sleepwalking, sleep-driving, or sleep-eating.
